Gossypol Inhibits Non-small Cell Lung Cancer Cells Proliferation by Targeting EGFR(L858R/T790M)

Background: Overexpression of epidermal growth factor receptor (EGFR) has been reported to be implicated in the pathogenesis of non-small cell lung cancer (NSCLC). Several EGFR inhibitors have been used in clinical treatment of NSCLC, but the emergence of EGFR(L858R/T790M) resistant mutation has red...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuwei, Lai, Huanling, Fan, Xingxing, Luo, Lianxiang, Duan, Fugang, Jiang, Zebo, Wang, Qianqian, Leung, Elaine Lai Han, Liu, Liang, Yao, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046546/
https://www.ncbi.nlm.nih.gov/pubmed/30038571
http://dx.doi.org/10.3389/fphar.2018.00728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046546/
https://www.ncbi.nlm.nih.gov/pubmed/30038571
http://dx.doi.org/10.3389/fphar.2018.00728

Ejemplares similares